CHICAGO, May 16 (Reuters) - An experimental Loxo Oncology Inc drug that targets cancers with mistakes in the RET gene led to tumor shrinkage in nearly 70 percent of patients regardless of where their cancer originated, according to preliminary data from a small study released on Wednesday.


00


Reuters

Latest News

FOX: Lena Dunham reveals she had surgery to remove her left ovary: 'It got worse and worse'

FOX: Jo Dee Messina letting God 'take charge' in cancer battle

FOX: Colorado rolls out new election security measures

FOX: Greenspan: Trump did the right thing cutting taxes

FOX: Where to get the nation’s best pizza

FOX: Chevy debuts Corvette ZR1's 755 hp V8 as crate engine in 1973 Chevelle

FOX: South Carolina officials warn about 'flushable' wipes after sending divers into 'raw sewage'

FOX: Elizabeth Warren struck a deal with the devil in claiming Native American ancestry for advancement

FOX: Canada starts legal sale of marijuana

FOX: Wipeout! Shark knocks surfer off her board

FOX: Ellison claimed ex-wife abused him during their marriage in unsealed divorce records

FOX: Martha Stewart starts streaming service

FOX: Delilah and Todd Starnes

FOX: Video shows devastating damage drones can inflict on planes

FOX: Lena Dunham reveals she had surgery to remove her left ovary: 'It got worse and worse'

FOX: Napolitano: Is Trump alienating female voters?

FOX: Jo Dee Messina letting God 'take charge' in cancer battle

FOX: Video shows devastating damage drones can inflict on planes

FOX: Lena Dunham reveals she had surgery to remove her left ovary: 'It got worse and worse'

FOX: Jo Dee Messina letting God 'take charge' in cancer battle

CBC: Shares of most pot companies sell off on 1st day of legalization

ABC: Mom's comics revealing to her husband why she's so exhausted is all of us

ABC: 'The View' discusses dating someone you disagree with politically

17 Related Articles from 2018-05-16